PortfoliosLab logoPortfoliosLab logo
Liquidia Corporation (LQDA)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US53635D2027
CUSIP
53635D202
IPO Date
Jul 26, 2018

Highlights

Market Cap
$3.78B
Enterprise Value
$3.71B
EPS (TTM)
-$0.76
Total Revenue (TTM)
$158.32M
Gross Profit (TTM)
$153.90M
EBITDA (TTM)
-$45.21M
Year Range
$11.26 - $46.67
Target Price
$50.67
ROA (TTM)
-21.02%
ROE (TTM)
-154.03%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Liquidia Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Liquidia Corporation (LQDA) has returned 9.42% so far this year and 155.86% over the past 12 months.


Liquidia Corporation

1D
7.28%
1M
21.66%
YTD
9.42%
6M
65.96%
1Y
155.86%
3Y*
76.11%
5Y*
68.72%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 26, 2018, LQDA's average daily return is +0.21%, while the average monthly return is +3.89%. At this rate, your investment would double in approximately 1.5 years.

Historically, 55% of months were positive and 45% were negative. The best month was May 2020 with a return of +85.5%, while the worst month was Aug 2019 at -44.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.

On a daily basis, LQDA closed higher 49% of trading days. The best single day was Jul 19, 2022 with a return of +45.3%, while the worst single day was Aug 19, 2024 at -30.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202622.91%-26.82%21.66%9.42%
202521.00%8.85%-4.78%-5.29%6.80%-16.49%50.00%48.10%-17.85%7.12%33.95%5.70%193.28%
20246.23%10.80%4.17%-12.88%0.16%-6.76%-0.58%-20.28%5.15%8.50%6.45%1.82%-2.24%
20233.61%14.70%-8.72%-2.89%21.01%-3.33%-1.66%-11.01%-7.71%2.68%9.98%68.02%88.85%
202216.22%14.31%10.97%-24.23%-25.37%7.39%12.50%17.64%-5.72%-10.11%2.66%26.89%30.80%
2021-7.12%2.19%-3.93%5.58%5.99%-4.98%-19.58%16.09%3.37%35.87%10.67%17.35%65.08%

Benchmark Metrics

Liquidia Corporation has an annualized alpha of 48.88%, beta of 0.99, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since July 27, 2018.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (86.36%) than losses (61.12%) — typical of diversified or defensive assets.
  • R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
48.88%
Beta
0.99
0.05
Upside Capture
86.36%
Downside Capture
61.12%

Return for Risk

Risk / Return Rank

LQDA ranks 89 for risk / return — in the top 89% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


LQDA Risk / Return Rank: 8989
Overall Rank
LQDA Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
LQDA Sortino Ratio Rank: 8989
Sortino Ratio Rank
LQDA Omega Ratio Rank: 8585
Omega Ratio Rank
LQDA Calmar Ratio Rank: 9090
Calmar Ratio Rank
LQDA Martin Ratio Rank: 8787
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Liquidia Corporation (LQDA) and compare them to a chosen benchmark (S&P 500 Index).


LQDABenchmarkDifference

Sharpe ratio

Return per unit of total volatility

2.28

0.90

+1.38

Sortino ratio

Return per unit of downside risk

2.76

1.39

+1.37

Omega ratio

Gain probability vs. loss probability

1.34

1.21

+0.12

Calmar ratio

Return relative to maximum drawdown

3.97

1.40

+2.57

Martin ratio

Return relative to average drawdown

9.04

6.61

+2.43

Explore LQDA risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Liquidia Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Liquidia Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Liquidia Corporation was 93.87%, occurring on Aug 4, 2021. Recovery took 1115 trading sessions.

The current Liquidia Corporation drawdown is 19.06%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.87%Oct 10, 2018709Aug 4, 20211115Jan 13, 20261824
-35.66%Feb 4, 202615Feb 25, 2026
-8.7%Oct 4, 20183Oct 8, 20181Oct 9, 20184
-8.64%Aug 23, 20187Aug 31, 20181Sep 4, 20188
-8.03%Sep 28, 20182Oct 1, 20181Oct 2, 20183

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Liquidia Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Liquidia Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for LQDA relative to other companies in the Biotechnology industry. Currently, LQDA has a P/S ratio of 21.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for LQDA in comparison with other companies in the Biotechnology industry. Currently, LQDA has a P/B value of 84.4. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items